Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Kardigan rises in Nasdaq debut after upsized $400 million IPO
Kardigan Announces Pricing of Upsized Initial Public Offering
Heart drug developer Kardigan targets $1.4 billion valuation in US IPO
Kardigan Begins Process For IPO On Cardiovascular Treatments Promise